Advertisement

Fungal Infections in Diabetics

  • Alexandro BonifazEmail author
  • Aline Armas-Vázquez
  • Andrés Tirado-Sánchez
Chapter

Abstract

Diabetes mellitus (DM) is the most common endocrine disorder, affecting 8.3% of the worldwide population, is strongly associated with the development of fungal infections and diseases connected with skin manifestations. Diabetes-associated skin diseases are often seen in clinical practice, among these cutaneous infections are involved. Cutaneous infections occur most commonly in type 2 (T2DM) than in type 1 diabetes (T1DM) [1–3]; and can be a cause of morbidity or mortality.

References

  1. 1.
    Mendes AL, Miot HA, Junior HV. Diabetes mellitus and the skin. An Bras Dermatol. 2017;92:8–20.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Duff M, Demidova O, Blackburn S, et al. Cutaneous manifestations of diabetes mellitus. Clin Diabetes. 2015;33:40–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Skorepová M. Mycoses and diabetes. Vnitr Lek. 2006;52:470–3.PubMedGoogle Scholar
  4. 4.
    Namazi MR, Yosipovitch G. Diabetes mellitus. In: Callen JP, Jorizzo JL, Bolognia JL, editors. Dermatological signs of internal disease. 4th ed. Philadelphia: Elsevier año; 2009. p. 189–98.CrossRefGoogle Scholar
  5. 5.
    Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16:S27–36.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Saul A, Martínez G. La Piel: en: Saul A. Lecciones de dermatología. 16 edición ed. Cd. De México: McGraw-Hill; 2014. p. 1–18.Google Scholar
  7. 7.
    Neumann E. Glycohistechia in psoriasis prior to and following medication of peroral antidiabetics. Dermatologica. 1960;120:120–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Campos de Macedo GM, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr. 2016;8:63.CrossRefGoogle Scholar
  9. 9.
    Romano C, Massai L, Asta F, Signorini AM. Prevalence of dermatophytic skin and nail infections in diabetic patients. Mycoses. 2001;44(3–4):83–6.CrossRefPubMedGoogle Scholar
  10. 10.
    García-Humbría L, Richard-Yegres N, Pérez-Blanco M, Yegres F, Mendoza M, Acosta A, Hernández R, Zárraga E. Superficial mycoses: comparative study between type 2 diabetic patients and a non-diabetic control group. Investig Clin. 2005;46:65–74.Google Scholar
  11. 11.
    Tosti A, Hay R, Arenas-Guzmán R. Patients at risk of onychomycosis—risk factor identification and active prevention. J Eur Acad Dermatol Venereol. 2005;19(Suppl 1):13–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Ozcan D, Seçkin D, Demirbilek M. In vitro antifungal susceptibility of dermatophyte strains causing tinea pedis and onychomycosis in patients with non-insulin-dependent diabetes mellitus: a case-control study. J Eur Acad Dermatol Venereol. 2010;24:1442–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Papini M, Cicoletti M, Fabrizi V, Landucci P. Skin and nail mycoses in patients with diabetic foot. G Ital Dermatol Venereol. 2013;148:603–8.PubMedGoogle Scholar
  14. 14.
    Bonifaz A. Micología médica básica. 5ª edición ed. Cd. de México: McGraw-Hill; 2015.Google Scholar
  15. 15.
    Oz Y, Qoraan I, Oz A, Balta I. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Int J Dermatol. 2017;56:68–74.CrossRefPubMedGoogle Scholar
  16. 16.
    Manzano-Gayosso P, Hernández-Hernández F, Méndez-Tovar LJ, Palacios-Morales Y, Córdova-Martínez E, Bazán-Mora E, López-Martinez R. Onychomycosis incidence in type 2 diabetes mellitus patients. Mycopathologia. 2008;166(1):41–5.CrossRefPubMedGoogle Scholar
  17. 17.
    Akkus G, Evran M, Gungor D, Karakas M, Sert M, Tetiker T. Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional—observational study. Pak J Med Sci. 2016;32:891–5.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Arenas R, Bonifaz A, Padilla MC, Arce M, Atoche C, Barba J, et al. Onychomycosis. A mexican survey. Eur J Dermatol. 2010;20:611–4.PubMedGoogle Scholar
  19. 19.
    Wijesuriya TM, Kottahachchi J, Gunasekara TD, Bulugahapitiya U, Ranasinghe KN, Neluka Fernando SS, Weerasekara MM. Aspergillus species: an emerging pathogen in onychomycosis among diabetics. Indian J Endocrinol Metab. 2015;19:811–6.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Bonifaz A, Cruz-Aguilar P, Ponce RM. Onychomycosis by molds. Report of 78 cases. Eur J Dermatol. 2007;17:70–2.PubMedGoogle Scholar
  21. 21.
    Hwang SM, Suh MK, Ha GY. Onychomycosis due to nondermatophytic molds. Ann Dermatol. 2012;24:175–80.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Cathcart S, Cantrell W, Be E. Onychomycosis and diabetes. J Eur Acad Dermatol Venereol. 2009;23:1119–22.CrossRefPubMedGoogle Scholar
  23. 23.
    Zane LT, Chanda S, Coronado D, Del Rosso J. Antifungal agents for onychomycosis: new treatment strategies to improve safety. Dermatol Online J. 2016;22(3.) pii: 13030/qt8dg124gs.Google Scholar
  24. 24.
    Edwards JE Jr, Tillman DB, Miller ME, et al. Infection and diabetes mellitus. West J Med. 1979;130:515–21.Google Scholar
  25. 25.
    de Leon EM, Jacober SJ, Sobel JD, et al. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002;2:1.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Kalra S, Chawla A. Diabetes and balanoposthitis. J Pak Med Assoc. 2016;66:1039–41.PubMedGoogle Scholar
  27. 27.
    Verma SB, Wollina U. Looking through the cracks of diabetic candidal balanoposthitis. Int J Gen Med. 2011;4:511–3.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Fernandez-Martinez RF, Jaimes-Aveldañez A, Hernández-Pérez F, et al. Oral Candida spp carriers: its prevalence in patients with type 2 diabetes mellitus. An Bras Dermatol. 2013;88:222–5.CrossRefGoogle Scholar
  29. 29.
    Dorko E, Baranová Z, Jenca A, Kizek P, Pilipcinec E, Tkáciková L. Diabetes mellitus and candidiases. Folia Microbiol (Praha). 2005;50:255–61.CrossRefGoogle Scholar
  30. 30.
    Asokan N, Binesh VG. Cutaneous problems in elderly diabetics: a population-based comparative cross-sectional survey. Indian J Dermatol Venereol Leprol. 2017;83:205–21.CrossRefPubMedGoogle Scholar
  31. 31.
    Martin ES, Elewski BE. Cutaneous fungal infections in the elderly. Clin Geriatr Med. 2002;18:59–75.CrossRefPubMedGoogle Scholar
  32. 32.
    Scheinfeld NS. Obesity and dermatology. Clin Dermatol. 2004;22:303–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Mahajan S, Koranne RV, Sharma SK. Cutaneous manifestation of diabetes mellitus. Indian J Dermatol Venereol Leprol. 2003;69:105–8.PubMedGoogle Scholar
  34. 34.
    Jayatilake JA, Tilakaratne WM, Panagoda GJ. Candidal onychomycosis: a mini-review. Mycopathologia. 2009;168(4):165–73.CrossRefPubMedGoogle Scholar
  35. 35.
    Abad-González J, Bonifaz A, Ponce RM. Onicomicosis por Candida asociada con diabetes mellitus. Dermatologia. Rev Mex. 2007;51:135–41.Google Scholar
  36. 36.
    Araiza-Santibánez J, Tirado-Sánchez A, González-Rodríguez AL, Vázquez-Escorcia RM, Ponce-Olivera RM, Bonifaz A. Onychomycosis in the elderly. A 2-year retrospective study of 138 cases. Rev Med Hosp Gen Méx. 2016;79(1):5–10.Google Scholar
  37. 37.
    Bonifaz A, Tirado-Sánchez A, Calderón L, et al. Cutaneous mucormycosis: mycological, clinical, and therapeutic aspects. Curr Fungal Infect Rep. 2015;9(4):229–37.  https://doi.org/10.1007/s12281-015-0236-z.CrossRefGoogle Scholar
  38. 38.
    Perusquía-Ortiz AM, Vázquez-González D, Bonifaz A. Opportunistic filamentous mycoses: aspergillosis, mucormycosis, phaeohyphomycosis and hyalohyphomycosis. J Dtsch Dermatol Ges. 2012;10:611–21.PubMedGoogle Scholar
  39. 39.
    Bonifaz A, Tirado-Sánchez A, Calderón L, et al. Mucormycosis in children: a study of 22 cases in a Mexican hospital. Mycoses. 2014;57 Suppl 3:79–84.CrossRefPubMedGoogle Scholar
  40. 40.
    Chow V, Khan S, Balogun A, et al. Invasive rhino-orbito-cerebral mucormycosis in a diabetic patient—the need for prompt treatment. Med Mycol Case Rep. 2014;23:5–9.Google Scholar
  41. 41.
    Di Carlo P, Pirrello R, Guadagnino G, et al. Multimodal surgical and medical treatment for extensive rhinocerebral mucormycosis in an elderly diabetic patient: a case report and literature review. Case Rep Med. 2014;2014:527062.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Bonifaz A, Tirado-Sánchez A, Ponce-Olivera RM. Granuloma de Majocchi. Gac Med Mex. 2008;144:427–33.PubMedGoogle Scholar
  43. 43.
    Erbagci Z. Deep dermatophytoses in association with atopy and diabetes mellitus: Majocchi’s granuloma tricophyticum or dermatophytic pseudomycetoma? Mycopathologia. 2002;154:163–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Tirado-Sánchez A, Ponce RM, Bonifaz A. Majocchi granuloma. (Dermatophytic granuloma): updated therapeutic options. Curr Fungal Infect Rep. 2015;9:204–12.CrossRefGoogle Scholar
  45. 45.
    Montes LF, Dobson H, Dodge BG, Knowles WR. Erythrasma and diabetes mellitus. Arch Dermatol. 1969;99:674–80.CrossRefPubMedGoogle Scholar
  46. 46.
    Ahmed I, Goldstein B. Diabetes mellitus. Clin Dermatol. 2006;24(4):237–46.CrossRefPubMedGoogle Scholar
  47. 47.
    Holdiness MR. Management of cutaneous erythrasma. Drugs. 2002;62:1131–41.CrossRefPubMedGoogle Scholar
  48. 48.
    de Andrade AL, Novaes MM, Germano AR, Luz KG, de Almeida Freitas R, Galvão HC. Acute primary actinomycosis involving the hard palate of a diabetic patient. J Oral Maxillofac Surg. 2014;72:537–41.CrossRefPubMedGoogle Scholar
  49. 49.
    Boyanova L, Kolarov R, Mateva L, Markovska R, Mitov I. Actinomycosis: a frequently forgotten disease. Future Microbiol. 2015;10:613–28.CrossRefPubMedGoogle Scholar
  50. 50.
    Bonifaz A, Tirado-Sánchez A, Calderón L, Montes de Oca G, Torres-Camacho P, Ponce RM. Treatment of cutaneous actinomycosis with amoxicillin/clavulanic acid. J Dermatol Treat. 2017;28:59–64.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Alexandro Bonifaz
    • 1
    Email author
  • Aline Armas-Vázquez
    • 1
  • Andrés Tirado-Sánchez
    • 1
  1. 1.Dermatology Service, Mycology DepartmentHospital General de México, “Dr. Eduardo Liceaga”Ciudad de MéxicoMéxico

Personalised recommendations